Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Short-Term Debt issuances (2016 - 2018)

Endonovo Therapeutics has reported Short-Term Debt issuances over the past 3 years, most recently at $59382.0 for Q4 2018.

  • Quarterly results put Short-Term Debt issuances at $59382.0 for Q4 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $65000.0 (changed N/A YoY), and the annual figure for FY2018 was $65000.0, up 150.0%.
  • Short-Term Debt issuances for Q4 2018 was $59382.0 at Endonovo Therapeutics, up from $110.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for ENDV hit a ceiling of $59382.0 in Q4 2018 and a floor of $110.0 in Q2 2016.
  • Median Short-Term Debt issuances over the past 3 years was $11745.0 (2015), compared with a mean of $18510.0.